4-(dimethoxyphosphorylmethylsulfonyl)aniline;2-[4-(dimethoxyphosphorylmethylsulfonyl)phenyl]-1-[3-(dimethylamino)-6-(4-methylphenyl)pyrazin-2-yl]ethanone;3-(dimethylamino)-6-(4-methylphenyl)pyrazine-2-carboxylic acid
C47H57N7O13P2S2 — CID 158032814
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(dimethoxyphosphorylmethylsulfonyl)aniline;2-[4-(dimethoxyphosphorylmethylsulfonyl)phenyl]-1-[3-(dimethylamino)-6-(4-methylphenyl)pyrazin-2-yl]ethanone;3-(dimethylamino)-6-(4-methylphenyl)pyrazine-2-carboxylic acid
4-(dimethoxyphosphorylmethylsulfonyl)aniline;2-[4-(dimethoxyphosphorylmethylsulfonyl)phenyl]-1-[3-(dimethylamino)-6-(4-methylphenyl)pyrazin-2-yl]ethanone;3-(dimethylamino)-6-(4-methylphenyl)pyrazine-2-carboxylic acid (PubChem CID 158032814) has the molecular formula C47H57N7O13P2S2 and a molecular weight of 1054.09 g/mol. Its IUPAC name is 4-(dimethoxyphosphorylmethylsulfonyl)aniline;2-[4-(dimethoxyphosphorylmethylsulfonyl)phenyl]-1-[3-(dimethylamino)-6-(4-methylphenyl)pyrazin-2-yl]ethanone;3-(dimethylamino)-6-(4-methylphenyl)pyrazine-2-carboxylic acid.
Molecular Properties
| Compound Name | 4-(dimethoxyphosphorylmethylsulfonyl)aniline;2-[4-(dimethoxyphosphorylmethylsulfonyl)phenyl]-1-[3-(dimethylamino)-6-(4-methylphenyl)pyrazin-2-yl]ethanone;3-(dimethylamino)-6-(4-methylphenyl)pyrazine-2-carboxylic acid |
|---|---|
| PubChem CID | 158032814 |
| Molecular Formula | C47H57N7O13P2S2 |
| Molecular Weight | 1054.09 g/mol |
| Exact Mass | 1053.29 |
| IUPAC Name | 4-(dimethoxyphosphorylmethylsulfonyl)aniline;2-[4-(dimethoxyphosphorylmethylsulfonyl)phenyl]-1-[3-(dimethylamino)-6-(4-methylphenyl)pyrazin-2-yl]ethanone;3-(dimethylamino)-6-(4-methylphenyl)pyrazine-2-carboxylic acid |
| SMILES | COP(=O)(CS(=O)(=O)c1ccc(CC(=O)c2nc(-c3ccc(C)cc3)cnc2N(C)C)cc1)OC.COP(=O)(CS(=O)(=O)c1ccc(N)cc1)OC.Cc1ccc(-c2cnc(N(C)C)c(C(=O)O)n2)cc1 |
| InChI | InChI=1S/C24H28N3O6PS.C14H15N3O2.C9H14NO5PS/c1-17-6-10-19(11-7-17)21-15-25-24(27(2)3)23(26-21)22(28)14-18-8-12-20(13-9-18)35(30,31)16-34(29,32-4)33-5;1-9-4-6-10(7-5-9)11-8-15-13(17(2)3)12(16-11)14(18)19;1-14-16(11,15-2)7-17(12,13)9-5-3-8(10)4-6-9/h6-13,15H,14,16H2,1-5H3;4-8H,1-3H3,(H,18,19);3-6H,7,10H2,1-2H3 |
| InChIKey | FHJPQRUDAAPYIO-UHFFFAOYSA-N |
| XLogP | 7.86 |
| TPSA | 277.77 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 71 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1054.09 |
| LogP ≤ 5 | 7.86 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 19 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158032814 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.